Skip to main content
main-content
Top

10-19-2017 | Retinopathy | Review | Article

Diabetic retinopathy: research to clinical practice

Journal:
Clinical Diabetes and Endocrinology

Authors: Anjali R. Shah, Thomas W. Gardner

Publisher: BioMed Central

Abstract

Diabetic Retinopathy (DR) is a leading cause of visual impairment in the United States. The CDC estimates that the prevalence of DR will triple from 2005 to 2050.
The report summarizes major past advances in diabetes research and their impact on clinical practice. Current paradigms and future directions are also discussed.
DR is a leading cause of visual impairment in the US. Significant progress has been made in the understanding and treatment of DR, but rising prevalence demands innovative approaches to management in the future.

Please log in to get access to this content

Related topics